companydata.dkcompanydata.dk

Sanofi A/S: Financial statements 2024

CVR: 19064301

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Sanofi A/S (CVR 19064301) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 452,617,000 and a net result of DKK 6,217,000 compared with DKK 3,697,000 the year before. That is a decrease of 14.2% compared with the year before. The profit margin was 1.4%. Equity in the 2024 report amounted to DKK 53,620,000. The solvency ratio was 27.9%. The company had 81 employees in the financial year.

Revenue
DKK 452,617,000
Gross Profit
DKK 107,095,000
Profit/Loss
DKK 6,217,000
Equity
DKK 53,620,000
Total Assets
DKK 192,036,000
Employees
81

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024452.6 mio.107.1 mio.6.2 mio.53.6 mio.81
2023527.6 mio.102.5 mio.3.7 mio.47.4 mio.83
2022530.9 mio.115 mio.15.9 mio.43.7 mio.85
2021591.1 mio.135.7 mio.22 mio.69.3 mio.86
2020563.5 mio.204.3 mio.67.2 mio.77.2 mio.100

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Birgitte Fyhn joins the board of Sanofi A/SNov 25, 2024

As of November 25, 2024, Birgitte Fyhn has joined the board of directors of Sanofi A/S.

Kirstin Jagd leaves the board of Sanofi A/SNov 25, 2024

As of November 25, 2024, Kirstin Jagd has left the board of directors of Sanofi A/S.

Sanofi A/S wins public contractNov 19, 2024

Sanofi A/S has won the tender "Amgros 2025 1.356.a" issued by Amgros I/S worth 4,530,400,000 DKK.

Sanofi A/S wins public contractOct 24, 2024

Sanofi A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.

Sanofi A/S wins public contractOct 23, 2024

Sanofi A/S has won the tender "Amgros 2025 1.1205.a" issued by Amgros I/S worth 73,155,425 DKK.

Daniel Andreas Sandgren joins the board of Sanofi A/SSep 2, 2024

As of September 2, 2024, Daniel Andreas Sandgren has joined the board of directors of Sanofi A/S.

Fiona Sylvie Simone de Bouvere leaves the board of Sanofi A/SSep 2, 2024

As of September 2, 2024, Fiona Sylvie Simone de Bouvere has left the board of directors of Sanofi A/S.

Daniel Andreas Sandgren joins Sanofi A/S as directorSep 2, 2024

As of September 2, 2024, Daniel Andreas Sandgren is registered as director of Sanofi A/S.

Fiona Sylvie Simone de Bouvere steps down as director of Sanofi A/SSep 2, 2024

As of September 2, 2024, Fiona Sylvie Simone de Bouvere has stepped down as director of Sanofi A/S.

Sanofi A/S wins public contractJul 10, 2024

Sanofi A/S has won the tender "Amgros 2025 1.1172.a" issued by Amgros I/S worth 1,360,000 DKK.

About Sanofi A/S

Sanofi A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SANOFI-AVENTIS DENMARK A/S and AVENTIS PHARMA A/S. The management consists of Odd Arne Gabriel Johannessen. The board consists of Birgitte Fyhn (chair), Hao Zheng and Odd Arne Gabriel Johannessen. The company is owned by Sanofi-Aventis Participations. The company has 87 employees (2026). In 2025, the company reported revenue of DKK 442,343,000 and a net result of DKK 5,043,000 compared with DKK 6,217,000 the year before. Equity in the 2025 report amounted to DKK 58,663,000.

Source: annual report 2025, Danish Business Authority